CYduct Diagnostics, Inc.

OTC: CYDX · Healthcare · Medical - Devices

PublicHQ Boston, MA · SuffolkCIK 0001388994Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 46

v0.1 · 5/100 weight · pillars only

↑ listing tenure, Piotroski F · ↓ Altman-Z, workforce scale

Methodology →

Revenue TTM

$65.7k

Rev growth YoY (TTM)

-9.5%

Net income (FY)

—

Employees

as of 2026-08-25

Market cap

$6.1M

as of 2026-08-25

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is CYduct Diagnostics, Inc.’s financial profile?

CYduct Diagnostics, Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Cardiac Biotech Solutions Inc.——Kairos Pharma, Ltd.——Eastgate Biotech Corp.——Reviva Pharmaceuticals Holdings, Inc.——Medicus Pharma Ltd. Common Stock——Adial Pharmaceuticals, Inc.——

Neighbors

Suffolk →

Vertex Pharmaceuticals Incorporated$12.0B88A American Tower Corporation$935.9M76B+State Street Corporation$13.9B67B NSTAR Electric Company——Toast, Inc.$6.2B67B PTC Inc.$2.7B83B+

Key facts

CEODom L. Gatto

SectorHealthcare

IndustryMedical - Devices

HeadquartersBoston, MA

ExchangeOTC: CYDX

Employees3

IPO date2000-01-14

Latest filings

No filings loaded.

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.